Bluefin Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bluefin Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-31,064	Closed	-$5.37M	–	574
2015 Q1	$5.37M	Sell	31,064 -32,317	-51%	-$4.74M	0.49%	54
2014 Q4	$7.29M	Buy	63,381 +13,461	+27%	+$1.63M	0.44%	45
2014 Q3	$7.8M	Buy	49,920 +9,790	+24%	+$1.42M	0.43%	49
2014 Q2	$5M	Buy	+40,130	New	+$4.44M	0.22%	82

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Bluefin Capital Management's SLXP Position: Q2 2015 in Review

Bluefin Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 31,064 shares — an estimated $5.37M sold.

Bluefin Capital Management first reported a position in SLXP in Q2 2014 and held it in 4 quarters. The position peaked at $7.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Bluefin Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Bluefin Capital Management sold 31,064 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $5.37M.
Bluefin Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 4 quarters.
Bluefin Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.8M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Bluefin Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.